| 000 | 01235 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512115358.0 | ||
| 264 | 0 | _c19750326 | |
| 008 | 197503s 0 0 eng d | ||
| 022 | _a0010-7824 | ||
| 024 | 7 |
_a10.1016/0010-7824(74)90012-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJubhari, S | |
| 245 | 0 | 0 |
_aContinuous microdose (0.3 mg) quingestanol acetate as an oral contraceptive agent. _h[electronic resource] |
| 260 |
_bContraception _cMar 1974 |
||
| 300 |
_a213-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMenstruation _xdrug effects |
| 650 | 0 | 4 |
_aMenstruation Disturbances _xchemically induced |
| 650 | 0 | 4 |
_aNorpregnadienes _xadministration & dosage |
| 650 | 0 | 4 |
_aOvulation _xdrug effects |
| 650 | 0 | 4 | _aParity |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 700 | 1 | _aLane, M E | |
| 700 | 1 | _aSobrero, A J | |
| 773 | 0 |
_tContraception _gvol. 9 _gno. 3 _gp. 213-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0010-7824(74)90012-2 _zAvailable from publisher's website |
| 999 |
_c4617435 _d4617435 |
||